Table 1. Characteristics of the entire... | American Society of Hematology

Table 1.

Characteristics of the entire indolent lymphoma cohort and of FL and MZL subsets

	Indolent lymphomas (N = 43 914)		FL (n = 23 384)		MZL (n = 20 530)		P value
	n	(%)	n	(%)	n	(%)	P value
Age (y)
<60	18 385	41.9	10 899	46.6	7 486	36.5	<.001
≥60	25 529	58.1	12 485	53.4	13 044	63.5
Gender
Male	21 010	47.8	11 719	50.1	9 291	45.3	<.001
Female	22 904	52.2	11 665	49.9	11 239	54.7
Race
White	37 823	86.1	20 878	89.3	16 945	82.5	<.001
Other	6 091	13.9	2 506	10.7	3 585	17.5
Ann Arbor stage
I-II	22 371	50.9	10 179	43.5	12 192	59.4	<.001
III-IV	21 543	49.1	13 205	56.5	8 338	40.6
Lymphoma subtype
FL	23 384	53.2	23 384	100	-	-
SMZL	2 005	4.6	-	-	2 005	9.8
NMZL	6 374	14.5	-	-	6 374	31
EMZL	12 151	27.7	-	-	12 151	59.2
Management
Observation	20 133	45.8	9 529	40.8	10 604	51.7	<.001
Treatment	23 781	54.2	13 855	59.2	9 926	48.3
HGT
No	42 423	96.6	22 399	95.8	20 024	97.5	NA
Yes	1 491	3.4	985	4.2	506	2.5

	Indolent lymphomas (N = 43 914)		FL (n = 23 384)		MZL (n = 20 530)		P value
	n	(%)	n	(%)	n	(%)	P value
Age (y)
<60	18 385	41.9	10 899	46.6	7 486	36.5	<.001
≥60	25 529	58.1	12 485	53.4	13 044	63.5
Gender
Male	21 010	47.8	11 719	50.1	9 291	45.3	<.001
Female	22 904	52.2	11 665	49.9	11 239	54.7
Race
White	37 823	86.1	20 878	89.3	16 945	82.5	<.001
Other	6 091	13.9	2 506	10.7	3 585	17.5
Ann Arbor stage
I-II	22 371	50.9	10 179	43.5	12 192	59.4	<.001
III-IV	21 543	49.1	13 205	56.5	8 338	40.6
Lymphoma subtype
FL	23 384	53.2	23 384	100	-	-
SMZL	2 005	4.6	-	-	2 005	9.8
NMZL	6 374	14.5	-	-	6 374	31
EMZL	12 151	27.7	-	-	12 151	59.2
Management
Observation	20 133	45.8	9 529	40.8	10 604	51.7	<.001
Treatment	23 781	54.2	13 855	59.2	9 926	48.3
HGT
No	42 423	96.6	22 399	95.8	20 024	97.5	NA
Yes	1 491	3.4	985	4.2	506	2.5

FL grade 1 to 2.

NA, not applicable.